Granules India secures first-to-file ANDA for Sodium Oxybate

Granules India secures first-to-file ANDA for Sodium Oxybate Extended-Release for Oral Suspension. This milestone could lead to 180-day marketing exclusivity upon FDA approval. The drug has a US market size of $400 million annually. Approval may boost revenues significantly in the coming years.

📊 STOCKS: GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma